Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Survival analysis of patients depending on M30 status of DTC

From: Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patients

  Patients with primary surgery Patients with NST
N 298 85
Deaths 21 7
 M30 positive 10/82 (12%) 4/41 (10%)
 M30 negative 11/216 (5%) 3/44 (7%)
P 0.032 n.s.
Overall survival*   
(M30 positive vs M30 negative) 0.008 n.s.
Relapses† 19 13
 M30 positive 7/82 (9%) 3/41 (7%)
 M30 negative 12/216 (6%) 10/44 (23%)
P n.s. 0.049
Relapse free survival* n.s. 0.128
(M30 positive vs M30 negative)   
  1. *Calculated by log-rank test. † Including local recurrence and distant metastases.